Figure 1
Figure 1. Transcriptional profile of endothelial and smooth muscle markers in hMSCs. (A) RT-PCR analysis of endothelial markers (VE-cadherin and PECAM1) in hMSCs at baseline and in hMSCs cocultured for 3 days with MS1 mouse endothelial cell line. (B) RT-PCR analysis of smooth muscle markers' mRNA in human mesenchymal stem cells, human aortic vascular smooth muscle cells (CRL-1999), and human dermal fibroblasts (CRL-2575). Water was used as negative control. (C-F) Protein expression of smooth muscle markers in hMSCs was confirmed by immunohistochemistry (α-smooth muscle actin [C], SM22α [D], desmin [E], and NG2 [F], yellow; DAPI, blue). Scale bar represents 50 μm.

Transcriptional profile of endothelial and smooth muscle markers in hMSCs. (A) RT-PCR analysis of endothelial markers (VE-cadherin and PECAM1) in hMSCs at baseline and in hMSCs cocultured for 3 days with MS1 mouse endothelial cell line. (B) RT-PCR analysis of smooth muscle markers' mRNA in human mesenchymal stem cells, human aortic vascular smooth muscle cells (CRL-1999), and human dermal fibroblasts (CRL-2575). Water was used as negative control. (C-F) Protein expression of smooth muscle markers in hMSCs was confirmed by immunohistochemistry (α-smooth muscle actin [C], SM22α [D], desmin [E], and NG2 [F], yellow; DAPI, blue). Scale bar represents 50 μm.

Close Modal

or Create an Account

Close Modal
Close Modal